ANIXA BIOSCIENCES, INC. — Income Charts
57 quarters of history · ending 2024-10-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$0
Cost of Revenue↑+3572.6% +$26K
$27K
R&D↓-8.6% -$139K
$1M
SG&A↑+12.4% +$159K
$1M
D&A↓-100.0% -$15K
$0
Operating Income↓-26.3% -$748K
$-4M
EBITDA↓-26.3% -$748K
$-4M
Interest Expense↓-60.4% -$11K
$7K
Interest Income↓-33.6% -$6K
$12K
Other Income/Expense
$0
Pretax Income↓-3.2% -$83K
$-3M
Tax Provision
$0
Net Income↓-30.5% -$766K
$-3M
Operating Margin
-1219.0%
Net Margin
-1089.5%
Effective Tax Rate
-51.1%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+14.0pts
7.0%
ETR Foreign Differential (pp)↓-0.0pts
0.2%
Operating Lease Cost↑+33.3% +$4K
$16K
Revenue YoY Variation
-100.0%
Income YoY Variation↓-24.6pts
-26.3%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↑+7.5pts
-3.6%